In conclusion, this study found that disease duration of SLE onset, respiratory involvement, menstrual abnormalities, Sjögren's syndrome, osteoporosis, Anti-RNP, CYC, MMF, biologics and largest daily dose of GC are risk factors for ONFH in female SLE patients. This evidence concerns the gene RNPC3 and systemic lupus erythematosus.